Dear JMCC Customers & Other Friends,
It’s been some time since we reached out to bring you up to date on JMCC. Please forgive that. But, despite the challenges posed for so many of us by the coronavirus, we’ve had our heads down for the past several months, working quietly and diligently away on a number of fronts to move the company forward – and in a very big way!
I’m thrilled now to be able to share some of the fruits of our labours with you, including two exciting major announcements and other related developments. Time for some good news, no?
First, is our agreement with the United Kingdom’s Drug Science to support its innovative Project Twenty21. This initiative is both ambitious -- in its scope, as one of the largest medical cannabis research projects ever undertaken – and visionary, in terms of its potential benefits for patients across the UK. Learn more about it here.
Our second major announcement is the launch of JMCC Scientific, a new division set up to research, develop, test and manufacture innovative cannabis-based treatments for a range of medical conditions. We see it as the “natural next step” for JMCC as the globe’s leading provider of premium Jamaican medical cannabis. We also believe it’s an important value-add to the total outsourcing solution for product developers we announced last year as it makes available another layer of in-depth scientific expertise to our outsourcing customers. Here’s more information about JMCC Scientific.
And, in that regard, I’m also delighted to announce the appointment of Carol Lindsay of the University of the West Indies’ Faculty of Basic Medical Sciences, as JMCC’s Chief Scientific Advisor. We’ll also be back to you shortly with news of additional key Scientific team members.
Our customers in Europe will be pleased to know that we’ve considerably accelerated our preparations for EU-GMP certification and now expect we’ll be well positioned for our inspection this summer (subject, of course, to whatever longer-lasting effects the coronavirus has on inspectors’ ability to travel). We’ve also embarked on an initiative to have JMCC’s already sustainably grown medical cannabis certified organic by the end of the year. We share more information in this Operations Update, which also includes news about some key management hires in Jamaica.
You can also read this update from JMCC’s Global Sales Team, learn about our new digital platform coming later this summer and upcoming events we’re involved with, including a planned “three-peat” as Title Sponsor of the Toronto Lift Conference & Expo this November (fingers crossed!). I am particularly chuffed by this as it was just three years ago that we launched JMCC in 2017, in a small booth in the back corner of the South Hall of the Metro Toronto Convention Centre, where the event will take place again this year.
Back in 2017, we were “testing the waters” to see how much interest there would be in Jamaican medical cannabis – and we were overwhelmed (in a good way!) by just how much interest there was. To be returning as Title Sponsor at Lift Toronto 2020, makes us extremely proud of our growth as a company, and very pleased with the lasting relationships we’ve built there and the consistently great experience we’ve enjoyed by participating.
In closing, I hope you and your loved ones stay safe and well over the next few months.
Best regards,
Diane Scott
Chair & CEO
JMCC Group